Biomedical Characteristics

The HUB Organoid Technology can be used to measure all biomedical characteristics of cells which have been developed over the last 50 years. Our assay services range from measuring viability of organoids in response to drug treatments (e.g. cancer), to complex imaging assays or -omics to study drug response. In addition, we have generated different formats to perform organoid assays in the traditional ‘3D’ cystic or budding shapes, organoids as ‘2D’ epithelium to study barrier function, transport, and interaction with the microbiome.

Frequently Requested Assays

The most frequently requested assays we perform are listed below. In addition, we offer immunohistochemistry, expression analysis, and most other generally used molecular biological techniques used in the lab.

On request, we can set up specific assays that are not listed and which we have not yet developed. Please don`t hesitate to contact us, we are happy to assist you further (

Forskolin-Induced Swelling Assay (FIS) Cell Viability and Cytotoxicity Assays Immuno-Oncology Assays Other

Forskolin-Induced Swelling Assay (FIS)

The Forskolin-Induced Swelling (FIS) assay is an imaging assay that, by measuring organoid swelling, measures CFTR function restoration and response to drug treatment. The FIS assay is a valuable tool in Cystic Fibrosis (CF) drug development and patient stratification and has shown its potential for clinical patient representation and personalized medicine for CF-subjects.

Cell Viability and Cytotoxicity Assays

HUB offers an extensive line of robust and innovative assays for determining cell viability and cytotoxicity. The assays have been developed in 3D culture conditions and can be multiplexed with imaging. Using a format of 384-well plates, up to 12,000 data points can be measured in one single assay to test the efficacy and toxicity of drugs.

Immuno-Oncology Assays

HUB has developed co-culture assays between immune cells (native or engineered) with normal and/or tumour organoids to evaluate either specific tumour recognition/killing of tumour organoids compared to normal or the interplay between immune cells and epithelial cells in the context of diseases such as Intestinal Bowel Diseases (IBD) or Chronic Obstructive Pulmonary Disease (COPD). Imaging, flow cytometry analysis and cytokine measurements are the main readouts for these assays.


  • Genotyping
  • Gene expression
  • DNA/RNA extraction
  • Molecular diagnostics
  • Gene editing
  • Mechanism of action studies
  • Screening
  • HIC and IF assays